
Ethics of a Randomized Trial of Periconceptual Vitamins
Ronald G. Munger, PhD, MPH;
Robert F. Woolson, PhD
University of Iowa College of Medicine Iowa City
JAMA. 1989;262(12):1633-1634.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
To the Editor.—
Mulinare and colleagues1 reported an association between periconceptional use of multivitamins by women and subsequent reduced risk of neural tube defects among their infants. Dr Holmes,2 in an accompanying editorial, interpreted this study as finding no protective effect of vitamins among black women, then speculated that genetic differences between whites and blacks may result in a greater responsiveness of whites to periconceptional vitamin supplements. Dr Holme's speculation is based on a failure to recognize the large type II error associated with small sample sizes and a faith in genetic determinism with no supporting data.
Any inferences regarding blacks in this study are hazardous because only 28 blacks were included among the cases reported in Table 2 of the article and only 2 of these reported vitamin use. If the true odds ratio among black women was similar to that found among white women (0.4), then
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|